Att B

Federal Register / Vol. 77, No. 61 / Thursday, March 29, 2012 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Announcement of Requirements and
Registration for Beat Down Blood
Pressure Challenge
Office of the National
Coordinator for Health Information
Technology, Department of Health and
Human Services (HHS).
ACTION: Federal Register Notice;
Correction.
AGENCY:

On March 22, 2012 the Office
of the National Coordinator for Health
Information Technology, located within
the Department of Health and Human
Services (HHS) published a notice in the
Federal Register (77 FR 17060)
announcing requirements and
registration for a Beat Down Blood
Pressure Video Challenge. This
challenge will not be open to the public
until Wednesday, March 28th. On 3/28,
we encourage you to visit http://
BloodPressure.Challenge.gov for a
complete set of rules and requirements
for this contest.
FOR FURTHER INFORMATION CONTACT: For
questions concerning this notice please
contact: Erin Poetter, MPH, Office of the
National Coordinator for Health
Information Technology, HHS, erin.
[email protected] or 202–205–3310.
SUMMARY:

Dated: March 21, 2012.
Erin Poetter,
Consumer e-Health Policy Analyst ONC,
Department of Health and Human Services.
[FR Doc. 2012–7485 Filed 3–28–12; 8:45 am]
BILLING CODE 4150–45–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

Assistant Secretary for
Planning and Evaluation, HHS.
ACTION: Notice of meeting.
AGENCY:

This notice announces the
public meeting of the Advisory Council
on Alzheimer’s Research, Care, and
Services (Advisory Council). Notice of
these meetings is given under the
Federal Advisory Committee Act
(5 U.S.C. App. 2, section 10(a)(1) and
(a)(2)). The Advisory Council on
Alzheimer’s Research, Care, and
Services provides advice on how to
prevent or reduce the burden of
Alzheimer’s disease and related
dementias on people with the disease
and their caregivers. The Advisory

mstockstill on DSK4VPTVN1PROD with NOTICES

SUMMARY:

VerDate Mar<15>2010

17:14 Mar 28, 2012

Jkt 226001

Council will discuss the Draft National
Plan to Address Alzheimer’s Disease,
and, as appropriate, make
recommendations to the Secretary of
HHS.
Meeting Date: April 17, 2012 from
9 a.m. to 4:15 p.m. EDT.
ADDRESSES: The meeting will be held at
the U.S. Department of Health and
Human Services, 200 Independence
Avenue SW., Room 800, Washington,
DC 20201.
Comments: Time is allocated on the
agenda to hear public comments. In lieu
of oral comments, formal written
comments may be submitted for the
record to Helen Lamont, OASPE, 200
Independence Avenue SW., Room 424E,
Washington, DC 20201. Comments may
also be sent to [email protected]. Those
submitting written comments should
identify themselves and any relevant
organizational affiliations.
FOR FURTHER INFORMATION CONTACT:
Helen Lamont (202) 690–7996,
[email protected]. Note: Seating
may be limited. Those wishing to attend
the meeting must send an email to
[email protected] and put (April 17
meeting attendance) in the Subject line
by Wednesday, April 11, 2012, so that
their names may be put on a list of
expected attendees and forwarded to the
security officers at the Department of
Health and Human Services. Any
interested member of the public who is
a non-U.S. citizen should include this
information at the time of registration to
ensure that the appropriate security
procedure to gain entry to the building
is carried out. Although the meeting is
open to the public, procedures
governing security and the entrance to
Federal buildings may change without
notice.

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

Topics of
the Meeting: The Advisory Council will
discuss the Draft National Plan to
Address Alzheimer’s Disease.
Procedure and Agenda: This meeting
is open to the public. The Advisory
Council will discuss the Draft National
Plan to Address Alzheimer’s Disease,
and, as appropriate, make
recommendations to the Secretary of
HHS.

Proposed Project

SUPPLEMENTARY INFORMATION:

Office of the Assistant Secretary for
Planning and Evaluation; Meeting of
the Advisory Council on Alzheimer’s
Research, Care, and Services

19015

Authority: 42 U.S.C. 11225; Section 2(e)(3)
of the National Alzheimer’s Project Act. The
panel is governed by provisions of Public
Law 92–463, as amended (5 U.S.C. Appendix
2), which sets forth standards for the
formation and use of advisory committees.
Sherry Glied,
Assistant Secretary for Planning and
Evaluation.
[FR Doc. 2012–7482 Filed 3–28–12; 8:45 am]
BILLING CODE P

PO 00000

Frm 00019

Fmt 4703

Sfmt 4703

Centers for Disease Control and
Prevention
[60Day–12–12GO]

Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–7570 and
send comments to Kimberly S. Lane, at
CDC 1600 Clifton Road, MS–D74,
Atlanta, GA 30333 or send an email to
[email protected].
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Colorectal Cancer Control Program
Indirect/Non-Medical Cost Study—
New—National Center for Chronic
Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Colorectal Cancer (CRC) is the second
leading cause of cancer-related deaths in
the United States, following lung
cancer. Based on scientific evidence
which indicates that regular screening is
effective in reducing CRC incidence and
mortality, regular CRC screening is now
recommended for average-risk persons.
Screening tests that may be used alone
or in combination include fecal occult
blood testing (FOBT), fecal
immunochemical testing (FIT), flexible
sigmoidoscopy, and/or colonoscopy.

E:\FR\FM\29MRN1.SGM

29MRN1

19016

Federal Register / Vol. 77, No. 61 / Thursday, March 29, 2012 / Notices

While screening rates have increased
over the past decade, screening
prevalence is still lower than desirable,
particularly among individuals with low
socioeconomic status. The indirect and
non-medical costs associated with CRC
screening, such as travel costs, may act
as barriers to screening. Understanding
these costs may provide insights that
can be used to reduce such barriers and
increase participation.
In 2005, CDC established a four-year
demonstration program at five sites to
screen low-income individuals aged 50–
64 years who had no health insurance
or inadequate health insurance for CRC.
In 2009, by applying lessons learned
from the demonstration program, CDC
designed and initiated the larger
population-based Colorectal Cancer
Control Program (CRCCP) at 29 sites.
The goals of the expanded program are
to reduce health disparities in CRC
screening, incidence and mortality by
promoting CRC screening for the eligible
population and providing CRC
screening to low-income adults over 50
years of age who have no health
insurance or inadequate health
insurance for CRC screening.
To date there has been no
comprehensive assessment of all the
costs associated with CRC screening,
especially indirect and non-medical
costs, incurred by the low-income
population served by the CRCCP. CDC

proposes to address this gap by
collecting information from a subset of
patients enrolled in the program. Those
who undergo screening by FIT or
colonoscopy will be asked to complete
a specialized questionnaire about the
time and personal expense associated
with their screening. Patients who
undergo fecal immunochemical testing
will be asked to complete the FIT
questionnaire, which is estimated to
take about 10 minutes. Patients who
undergo colonoscopy will be asked to
complete the Colonoscopy
questionnaire, which includes
additional questions about the
preparation and recovery associated
with this procedure. The estimated
burden per response for the
Colonoscopy questionnaire is 25
minutes. Demographic information will
be collected from all patients who
participate in the study. Participation in
the study is voluntary, but patients will
be offered an incentive in the form of a
gift card.
CDC plans to conduct the information
collection in partnership with providers
in five states (Alabama, Arizona,
Colorado, New York, and Pennsylvania).
Each provider site will administer the
survey until it reaches a target number
of responses. Targets for each site range
between 75 and 150 completed
questionnaires, depending on the
volume of patients screened. Each

participating provider will make patient
navigators available to assist patients
with coordinating the screening process
and completing the questionnaires.
Providers will be reimbursed for patient
navigator time and administrative
expense associated with data collection.
Across the five participating sites, the
estimated cost of this data collection is
approximately $50,000.
This information collection will be
used to produce estimates of the
personal costs incurred by patients who
undergo CRC screening by FIT or
colonoscopy, and to improve
understanding of these costs as potential
barriers to participation. Study findings
will be disseminated through reports,
presentations, and publications. Results
will also be used by participating sites,
CDC, and other federal agencies to
improve delivery of CRC screening
services and to increase screening rates
among low-income adults over 50 years
of age who have no health insurance or
inadequate health insurance for CRC
screening.
OMB approval is requested for one
year. Each respondent will have the
option of completing a hardcopy
questionnaire or an on-line
questionnaire. No identifiable
information will be collected by CDC or
CDC’s data collection contractor. There
are no costs to respondents other than
their time.

ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents

Average
burden per
response
(in hours)

Total burden
(in hours)

Form type

Patients Served by the Colorectal
Cancer Control Program.

FIT questionnaire .............................

300

1

10/60

50

Colonoscopy questionnaire ..............

315

1

25/60

131

...........................................................

........................

........................

........................

181

Total ...........................................

Dated: March 23, 2012.
Ron A. Otten,
Director, Office of Scientific Integrity, Office
of the Associate Director for Science (OADS),
Office of the Director, Centers for Disease
Control and Prevention.

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–12–0040]

[FR Doc. 2012–7534 Filed 3–28–12; 8:45 am]

Proposed Data Collections Submitted
for Public Comment and
Recommendations

BILLING CODE 4163–18–P

mstockstill on DSK4VPTVN1PROD with NOTICES

Number of
responses
per
respondent

Type of respondent

In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To

VerDate Mar<15>2010

17:14 Mar 28, 2012

Jkt 226001

PO 00000

Frm 00020

Fmt 4703

Sfmt 4703

request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–7570 and
send comments to Ron Otten, at CDC
1600 Clifton Road, MS–D74, Atlanta,
GA 30333 or send an email to
[email protected].
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be

E:\FR\FM\29MRN1.SGM

29MRN1